Cargando…

Metabolic engineering of Escherichia coli for efficient production of l-alanyl-l-glutamine

BACKGROUND: l-Alanyl-l-glutamine (AQ) is a functional dipeptide with high water solubility, good thermal stability and high bioavailability. It is widely used in clinical treatment, post-operative rehabilitation, sports health care and other fields. AQ is mainly produced via chemical synthesis which...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Jiangming, Yang, Wei, Wang, Bohua, Liu, Qun, Zhong, Xiaotong, Gao, Quanxiu, Liu, Jiezheng, Huang, Jianzhong, Lin, Baixue, Tao, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291740/
https://www.ncbi.nlm.nih.gov/pubmed/32527330
http://dx.doi.org/10.1186/s12934-020-01369-2
_version_ 1783545967410151424
author Zhu, Jiangming
Yang, Wei
Wang, Bohua
Liu, Qun
Zhong, Xiaotong
Gao, Quanxiu
Liu, Jiezheng
Huang, Jianzhong
Lin, Baixue
Tao, Yong
author_facet Zhu, Jiangming
Yang, Wei
Wang, Bohua
Liu, Qun
Zhong, Xiaotong
Gao, Quanxiu
Liu, Jiezheng
Huang, Jianzhong
Lin, Baixue
Tao, Yong
author_sort Zhu, Jiangming
collection PubMed
description BACKGROUND: l-Alanyl-l-glutamine (AQ) is a functional dipeptide with high water solubility, good thermal stability and high bioavailability. It is widely used in clinical treatment, post-operative rehabilitation, sports health care and other fields. AQ is mainly produced via chemical synthesis which is complicated, time-consuming, labor-intensive, and have a low yield accompanied with the generation of by-products. It is therefore highly desirable to develop an efficient biotechnological process for the industrial production of AQ. RESULTS: A metabolically engineered E. coli strain for AQ production was developed by over-expressing l-amino acid α-ligase (BacD) from Bacillus subtilis, and inactivating the peptidases PepA, PepB, PepD, and PepN, as well as the dipeptide transport system Dpp. In order to use the more readily available substrate glutamic acid, a module for glutamine synthesis from glutamic acid was constructed by introducing glutamine synthetase (GlnA). Additionally, we knocked out glsA–glsB to block the first step in glutamine metabolism, and glnE–glnB involved in the ATP-dependent addition of AMP/UMP to a subunit of glutamine synthetase, which resulted in increased glutamine supply. Then the glutamine synthesis module was combined with the AQ synthesis module to develop the engineered strain that uses glutamic acid and alanine for AQ production. The expression of BacD and GlnA was further balanced to improve AQ production. Using the final engineered strain p15/AQ10 as a whole-cell biocatalyst, 71.7 mM AQ was produced with a productivity of 3.98 mM/h and conversion rate of 71.7%. CONCLUSION: A metabolically engineered strain for AQ production was successfully developed via inactivation of peptidases, screening of BacD, introduction of glutamine synthesis module, and balancing the glutamine and AQ synthesis modules to improve the yield of AQ. This work provides a microbial cell factory for efficient production of AQ with industrial potential. [Image: see text]
format Online
Article
Text
id pubmed-7291740
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72917402020-06-12 Metabolic engineering of Escherichia coli for efficient production of l-alanyl-l-glutamine Zhu, Jiangming Yang, Wei Wang, Bohua Liu, Qun Zhong, Xiaotong Gao, Quanxiu Liu, Jiezheng Huang, Jianzhong Lin, Baixue Tao, Yong Microb Cell Fact Research BACKGROUND: l-Alanyl-l-glutamine (AQ) is a functional dipeptide with high water solubility, good thermal stability and high bioavailability. It is widely used in clinical treatment, post-operative rehabilitation, sports health care and other fields. AQ is mainly produced via chemical synthesis which is complicated, time-consuming, labor-intensive, and have a low yield accompanied with the generation of by-products. It is therefore highly desirable to develop an efficient biotechnological process for the industrial production of AQ. RESULTS: A metabolically engineered E. coli strain for AQ production was developed by over-expressing l-amino acid α-ligase (BacD) from Bacillus subtilis, and inactivating the peptidases PepA, PepB, PepD, and PepN, as well as the dipeptide transport system Dpp. In order to use the more readily available substrate glutamic acid, a module for glutamine synthesis from glutamic acid was constructed by introducing glutamine synthetase (GlnA). Additionally, we knocked out glsA–glsB to block the first step in glutamine metabolism, and glnE–glnB involved in the ATP-dependent addition of AMP/UMP to a subunit of glutamine synthetase, which resulted in increased glutamine supply. Then the glutamine synthesis module was combined with the AQ synthesis module to develop the engineered strain that uses glutamic acid and alanine for AQ production. The expression of BacD and GlnA was further balanced to improve AQ production. Using the final engineered strain p15/AQ10 as a whole-cell biocatalyst, 71.7 mM AQ was produced with a productivity of 3.98 mM/h and conversion rate of 71.7%. CONCLUSION: A metabolically engineered strain for AQ production was successfully developed via inactivation of peptidases, screening of BacD, introduction of glutamine synthesis module, and balancing the glutamine and AQ synthesis modules to improve the yield of AQ. This work provides a microbial cell factory for efficient production of AQ with industrial potential. [Image: see text] BioMed Central 2020-06-11 /pmc/articles/PMC7291740/ /pubmed/32527330 http://dx.doi.org/10.1186/s12934-020-01369-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhu, Jiangming
Yang, Wei
Wang, Bohua
Liu, Qun
Zhong, Xiaotong
Gao, Quanxiu
Liu, Jiezheng
Huang, Jianzhong
Lin, Baixue
Tao, Yong
Metabolic engineering of Escherichia coli for efficient production of l-alanyl-l-glutamine
title Metabolic engineering of Escherichia coli for efficient production of l-alanyl-l-glutamine
title_full Metabolic engineering of Escherichia coli for efficient production of l-alanyl-l-glutamine
title_fullStr Metabolic engineering of Escherichia coli for efficient production of l-alanyl-l-glutamine
title_full_unstemmed Metabolic engineering of Escherichia coli for efficient production of l-alanyl-l-glutamine
title_short Metabolic engineering of Escherichia coli for efficient production of l-alanyl-l-glutamine
title_sort metabolic engineering of escherichia coli for efficient production of l-alanyl-l-glutamine
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291740/
https://www.ncbi.nlm.nih.gov/pubmed/32527330
http://dx.doi.org/10.1186/s12934-020-01369-2
work_keys_str_mv AT zhujiangming metabolicengineeringofescherichiacoliforefficientproductionoflalanyllglutamine
AT yangwei metabolicengineeringofescherichiacoliforefficientproductionoflalanyllglutamine
AT wangbohua metabolicengineeringofescherichiacoliforefficientproductionoflalanyllglutamine
AT liuqun metabolicengineeringofescherichiacoliforefficientproductionoflalanyllglutamine
AT zhongxiaotong metabolicengineeringofescherichiacoliforefficientproductionoflalanyllglutamine
AT gaoquanxiu metabolicengineeringofescherichiacoliforefficientproductionoflalanyllglutamine
AT liujiezheng metabolicengineeringofescherichiacoliforefficientproductionoflalanyllglutamine
AT huangjianzhong metabolicengineeringofescherichiacoliforefficientproductionoflalanyllglutamine
AT linbaixue metabolicengineeringofescherichiacoliforefficientproductionoflalanyllglutamine
AT taoyong metabolicengineeringofescherichiacoliforefficientproductionoflalanyllglutamine